ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
오베티콜산 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간 동안의 성장은 원발성 담즙성 담관염(PBC) 및 비알코올성 지방간염(NASH)의 유병률 증가, 혁신적인 간 질환 치료에 대한 수요 증가, 간 질환 및 사용 가능한 치료에 대한 인식 증가, 신흥 시장의 글로벌 의료 접근성 확대, 간 질환 인식에 대한 관심 증가에 기인할 수 있습니다. 이 기간 동안의 주요 트렌드에는 NASH 치료법의 채택, 추가 개발을 위한 파트너십 및 협업, 모니터링 및 규정 준수를 위한 디지털 건강 도구의 통합, 비알코올성 지방간 질환(NAFLD) 치료로의 전환, 간 질환 바이오마커의 발전, 진단 기술의 발전 등이 있습니다.
간 질환의 유병률 증가는 오베티콜산 시장의 성장을 가속할 것으로 예측됩니다. 간 질환은 간 기능을 손상시키는 질병입니다. 간경변, 최종 간부전으로 이어지는 알코올의 과다 섭취 등의 요인에 기인하고 있습니다. 오베티콜산은 담즙산 축적을 줄이고 염증을 줄이며 섬유증 진행을 늦춰 간 기능을 개선하는 파네소이드 X 수용체(FXR)를 활성화하여 간 질환 치료에 도움을 줍니다. 예를 들어, 2024년 12월 영국 보건 개선 및 격차 사무소는 알코올성 간 질환으로 인한 조기 사망이 2022년 5,776명에서 2023년 5,984명으로 3.6% 증가했다고 보고했습니다.
오베티콜산 시장에서 사업을 전개하는 기업은 간 질환 치료와 환자의 예후를 개선하기 위해 FXR 작용제와 같은 혁신적인 제품에 노력하고 있습니다. FXR 작용제는 간에서 담즙산 대사, 염증 및 섬유증을 조절하는 데 관여하는 수용체인 FXR을 활성화하는 화합물입니다. 이러한 작용제는 원발성 담즙성 담관염(PBC) 및 비알코올성 지방간염(NASH)과 같은 질환을 치료하고 간 기능을 개선하는 데 사용됩니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 바이오 제약 회사인 인터셉트 파마슈티컬스는 미국 식품의약국(FDA)이 PBC 치료를 위한 오칼리바의 추가 신약 허가 신청(sNDA)을 승인했다고 발표했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 오베티콜산 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 오베티콜산 시장 : 성장률 분석
세계의 오베티콜산 시장 실적 : 규모와 성장(2019-2024년)
세계의 오베티콜산 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 오베티콜산 전체 시장(TAM)
제6장 시장 세분화
세계의 오베티콜산 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정제
캡슐
기타 제품 유형
세계의 오베티콜산 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 오베티콜산 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
원발성 담즙성 담관염
비알코올성 지방간염
기타 용도
세계의 오베티콜산 시장 : 정제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
즉시 방출 정제
연장 방출 정제
세계의 오베티콜산 시장 : 캡슐 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소프트 젤라틴 캡슐
하드 젤라틴 캡슐
세계의 오베티콜산 시장 : 기타 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 현탁액
주사제 제형
제7장 지역별/국가별 분석
세계의 오베티콜산 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 오베티콜산 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
오베티콜산 시장 : 경쟁 구도
오베티콜산 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline(GSK) : 개요, 제품 및 서비스, 전략 및 재무 분석
Gilead Sciences Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Amgen Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Genfit : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceutical Industries Ltd.
Regeneron Pharmaceuticals
WuXi AppTec
Bayer AG
Sumitomo Dainippon Pharma Co. Ltd.
Horizon Therapeutics
Dr. Reddy's Laboratories
Lupin Limited
Hepalink Pharmaceutical Group5
Alembic Pharmaceuticals
Intercept Pharmaceuticals Inc.
Enanta Pharmaceuticals
Viva Life sciences
Omgene Life Sciences Pvt. Ltd.
Zydus Cadila
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
오베티콜산 시장(2029년) : 새로운 기회를 제공하는 국가
오베티콜산 시장(2029년) : 새로운 기회를 제공하는 부문
오베티콜산 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Obeticholic acid is a medication primarily used to treat liver diseases, particularly for patients with primary biliary cholangitis (PBC), a chronic liver condition. It is a synthetic bile acid that activates a receptor called the farnesoid X receptor (FXR), which helps regulate bile acid production, liver function, and inflammation.
The main product types of obeticholic acid include tablets, capsules, and other forms. Tablets are solid dosage forms designed for convenient oral administration. The drug is distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to treat nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.
The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including the obeticholic acid industry global market size, regional shares, competitors with the obeticholic acid market share, detailed obeticholic acid segments, market trends, and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The obeticholic acid market size has grown rapidly in recent years. It will grow from $0.90 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC), the rising incidence of non-alcoholic steatohepatitis (NASH), the expansion of healthcare infrastructure in emerging markets, higher rates of liver disease diagnostics and screening, increasing healthcare expenditure, and greater investment in liver disease research.
The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth during the forecast period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH), growing demand for innovative liver disease treatments, rising awareness of liver diseases and available treatments, expansion of global healthcare access in emerging markets, and increasing focus on liver disease awareness. Key trends during this period include the adoption of NASH treatments, partnerships and collaborations for further development, integration of digital health tools for monitoring and compliance, a shift toward non-alcoholic fatty liver disease (NAFLD) treatment, advancements in liver disease biomarkers, and progress in diagnostic technologies.
The increasing prevalence of liver diseases is expected to drive the growth of the obeticholic acid market. Liver diseases are conditions that impair the liver's ability to function effectively. This rise in liver diseases can be attributed to factors such as excessive alcohol consumption, which damages liver cells, leading to inflammation, cirrhosis, and eventual liver failure. Obeticholic acid aids in treating liver disease by activating the farnesoid X receptor (FXR), which helps reduce bile acid buildup, decreases inflammation, and slows fibrosis progression, thereby improving liver function. For example, in December 2024, the UK's Office for Health Improvement and Disparities reported a 3.6% increase in premature deaths from alcoholic liver disease, reaching 5,984 in 2023, up from 5,776 in 2022. This rise in liver disease cases is driving the market for obeticholic acid.
Companies operating in the obeticholic acid market are working on innovative products such as FXR agonists to improve liver disease treatment and patient outcomes. FXR agonists are compounds that activate the FXR, a receptor involved in regulating bile acid metabolism, inflammation, and fibrosis in the liver. These agonists are used to treat conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH) and help enhance liver function. For instance, in February 2024, Intercept Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat PBC. The FDA's acceptance indicates progress toward validating the clinical benefits of obeticholic acid for PBC treatment.
In July 2022, Advanz Pharma Corp. Limited, a UK-based pharmaceutical company, acquired Intercept Pharmaceuticals. With this acquisition, Advanz Pharma aimed to strengthen its presence in the specialty pharmaceuticals sector by adding the commercialization rights to Ocaliva (obeticholic acid) for the treatment of PBC. Intercept Pharmaceuticals, a U.S.-based biopharmaceutical company, specializes in providing obeticholic acid.
Major players in the obeticholic acid market are Pfizer Inc., GlaxoSmithKline (GSK), Gilead Sciences Inc., Amgen Inc., Genfit, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, WuXi AppTec, Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Dr. Reddy's Laboratories, Lupin Limited, Hepalink Pharmaceutical Group5, Alembic Pharmaceuticals, Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals, Viva Life sciences, Omgene Life Sciences Pvt. Ltd., Zydus Cadila.
North America was the largest region in the Obeticholic Acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in obeticholic acid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Obeticholic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Tablets; Capsules; Other Product Types
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
Sub Segments:
1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets
2) By Capsules: Soft Gelatin Capsules; Hard Gelatin Capsules
3) By Other Product Types: Oral Suspensions; Injectable Formulations
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Obeticholic Acid Market Characteristics
3. Obeticholic Acid Market Trends And Strategies
4. Obeticholic Acid Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Obeticholic Acid Growth Analysis And Strategic Analysis Framework
5.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Obeticholic Acid Market Growth Rate Analysis
5.4. Global Obeticholic Acid Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Obeticholic Acid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Obeticholic Acid Total Addressable Market (TAM)
6. Obeticholic Acid Market Segmentation
6.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Other Product Types
6.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Biliary Cholangitis
Nonalcoholic Steatohepatitis
Other Applications
6.4. Global Obeticholic Acid Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Extended-Release Tablets
6.5. Global Obeticholic Acid Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Soft Gelatin Capsules
Hard Gelatin Capsules
6.6. Global Obeticholic Acid Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Suspensions
Injectable Formulations
7. Obeticholic Acid Market Regional And Country Analysis
7.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
